Masaki Kumondai

12PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCellular nervous systemPharmaceutical delivery technologiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 20, 2026
Liquid Chromatography-Tandem Mass Spectrometry Quantification of Diet-Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects.

|Dec 17, 2024
Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia.

Toshihiro Sato, Takeshi Kawabata, Masaki Kumondai

|Oct 25, 2024
Global and Targeted Metabolomics for Revealing Metabolomic Alteration in Niemann-Pick Disease Type C Model Cells.

Masahiro Watanabe, Masamitsu Maekawa, Keitaro Miyoshi

|Sep 28, 2024
Development of Simultaneous Drug Concentration Measurement Method Using an Automated Pretreatment Liquid Chromatography/Tandem Mass Spectrometry System for Therapeutic Drug Monitoring.

Yu Sato, Hiroki Kondo, Yuji Sato

|Sep 27, 2024
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma.

Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato

|Jul 12, 2024
Relevance of plasma lenvatinib concentrations and endogenous urinary cytochrome P450 3A activity biomarkers in clinical practice.

Masaki Kumondai, Reika Ogawa, Nagomi Hayashi

Pageof 2

Frequent Collaborators

10 joint publications

Masamitsu Maekawa

8 joint publications

Toshihiro Sato

8 joint publications

Yu Sato

3 joint publications

Hiroaki Yamaguchi